Teleflex Incorporated (TFX) To Go Ex-Dividend on March 6th

Teleflex Incorporated (NYSE:TFX) declared a quarterly dividend on Tuesday, February 24th. Investors of record on Friday, March 6th will be paid a dividend of 0.34 per share by the medical technology company on Tuesday, March 31st. This represents a c) dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Friday, March 6th.

Teleflex has a dividend payout ratio of 9.7% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Teleflex to earn $15.18 per share next year, which means the company should continue to be able to cover its $1.36 annual dividend with an expected future payout ratio of 9.0%.

Teleflex Stock Performance

NYSE:TFX opened at $122.02 on Wednesday. Teleflex has a twelve month low of $100.18 and a twelve month high of $143.32. The company has a quick ratio of 2.01, a current ratio of 2.54 and a debt-to-equity ratio of 0.81. The stock’s 50-day simple moving average is $111.31 and its 200 day simple moving average is $118.70. The firm has a market capitalization of $5.39 billion, a PE ratio of -5.94, a price-to-earnings-growth ratio of 0.76 and a beta of 0.87.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, February 26th. The medical technology company reported $1.93 EPS for the quarter, missing analysts’ consensus estimates of $3.73 by ($1.80). Teleflex had a positive return on equity of 14.30% and a negative net margin of 30.56%.The company had revenue of $569.00 million during the quarter, compared to the consensus estimate of $912.57 million. During the same period last year, the company posted $3.89 EPS. The firm’s revenue was down 28.5% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, analysts anticipate that Teleflex will post 13.98 EPS for the current fiscal year.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.